Table 2.
Author | Case/ Representative |
Representative/Nonexposed | Controls/Exposure | Definition/Outcome not present | Confounding | Exposure/Outcome | Method/Follow-up | Nonresponse/Adequate follow-up | Score |
---|---|---|---|---|---|---|---|---|---|
Puzzono 2022 (22) | * | * | * | * | – | * | * | * | 7 |
Nguyen 2022 (23) | – | * | – | * | ** | * | * | * | 7 |
McDowell 2022 (24) | * | * | * | * | * | * | * | * | 8 |
Li 2022 (25) | – | * | * | * | ** | * | * | * | 8 |
Jin 2022 (26) | * | * | * | * | ** | * | * | * | 9 |
Pang 2022 (27) | * | * | * | * | ** | * | – | – | 7 |
Danial 2022 (28) | * | * | * | * | – | – | * | * | 6 |
Archambault 2021 (29) | * | * | * | * | * | * | * | * | 8 |
Kim 2021 (30) | – | * | – | * | ** | – | * | * | 6 |
Zheng 2021 (31) | – | * | * | * | ** | * | * | * | 8 |
Yue 2021 (32) | – | * | * | * | ** | * | * | * | 8 |
Schumacher 2021 (33) | * | * | * | * | ** | * | * | * | 9 |
Nguyen 2021 (34) | – | * | * | * | ** | * | * | * | 8 |
Joh 2021 (35) | – | * | * | * | ** | * | * | * | 8 |
Chen 2021 (36) | * | * | * | * | ** | * | * | * | 9 |
Hur 2021 (37) | – | * | * | * | ** | * | * | * | 8 |
Chang 2021 (38) | – | * | * | * | ** | * | – | * | 7 |
Demb 2020 (39) | – | * | * | * | ** | * | * | * | 8 |
Dash 2020 (40) | – | * | – | * | ** | * | * | * | 7 |
Low 2020 (13) | * | – | * | * | * | – | * | * | 6 |
Gausman 2020 (41) | * | * | – | * | * | – | * | * | 6 |
L'Heureux 2019 (42) | * | * | – | * | * | – | * | * | 6 |
Liu 2019 (43) | – | * | – | * | ** | * | * | * | 7 |
Syed 2019 (44) | * | * | – | * | ** | – | * | * | 7 |
Glover 2019 (15) | * | * | * | * | ** | – | * | * | 8 |
Nguyen 2018 (45) | – | * | * | * | ** | * | * | * | 8 |
Levi 2017 (46) | * | * | * | * | – | * | * | * | 7 |
Kwak 2016 (21) | * | * | * | * | * | – | – | * | 6 |
Wu 2013 (47) | * | * | * | * | – | * | – | * | 6 |
Søndergaard 2013 (48) | * | * | * | * | – | * | * | * | 7 |
Rosato 2013 (49) | * | * | – | * | ** | * | * | * | 8 |
Ghadirian 1998 (50) | * | * | * | * | – | * | * | – | 6 |
Negri 1998 (51) | * | * | * | * | – | – | * | * | 6 |
Fuchs 1994 (52) | – | * | – | * | ** | * | * | * | 7 |
St John 1993 (53) | * | * | – | * | – | * | * | * | 6 |
Peter 1989 (54) | * | * | * | * | – | * | * | * | 7 |
The NOS is a quality scale that evaluates studies based on 3 broad categories: selection (maximum of four stars); comparability (maximum of two stars); and exposure/outcome (maximum of three stars). *, one point; **, two points; -, no points.